Green Cross Lab Cell Corporation (144510) - Total Liabilities

Latest as of June 2026: ₩145.87 Billion KRW ≈ $98.85 Million USD

Based on the latest financial reports, Green Cross Lab Cell Corporation (144510) has total liabilities worth ₩145.87 Billion KRW (≈ $98.85 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 144510 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Green Cross Lab Cell Corporation - Total Liabilities Trend (2015–2025)

This chart illustrates how Green Cross Lab Cell Corporation's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 144510 total assets.

Green Cross Lab Cell Corporation Competitors by Total Liabilities

The table below lists competitors of Green Cross Lab Cell Corporation ranked by their total liabilities.

Company	Country	Total Liabilities
Humm Group Ltd AU:HUM	Australia	AU$4.82 Billion
Simmtech Holdings Co. Ltd KQ:036710	Korea	₩1.41 Trillion
Espey Mfg & Electronics Corp NYSE MKT:ESP	USA	$33.87 Million
JTC Inc KQ:950170	Korea	₩152.77 Billion
Punjab Chemicals & Crop Protection Limited NSE:PUNJABCHEM	India	Rs2.93 Billion
Lucky Cement Co TW:1108	Taiwan	NT$4.92 Billion
6K Additive Inc AU:6KA	Australia	AU$6.18 Million
GRIGEO AB EO -29 F:WM8	Germany	€64.76 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Green Cross Lab Cell Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Green Cross Lab Cell Corporation (144510) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.52	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.79	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.44	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Green Cross Lab Cell Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Green Cross Lab Cell Corporation (2015–2025)

The table below shows the annual total liabilities of Green Cross Lab Cell Corporation from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩113.31 Billion ≈ $76.79 Million	-6.01%
2024-12-31	₩120.56 Billion ≈ $81.70 Million	-2.53%
2023-12-31	₩123.69 Billion ≈ $83.82 Million	-10.42%
2022-12-31	₩138.07 Billion ≈ $93.57 Million	+2.60%
2021-12-31	₩134.57 Billion ≈ $91.20 Million	+360.97%
2020-12-31	₩29.19 Billion ≈ $19.78 Million	+21.56%
2019-12-31	₩24.02 Billion ≈ $16.27 Million	+151.56%
2018-12-31	₩9.55 Billion ≈ $6.47 Million	+35.76%
2017-12-31	₩7.03 Billion ≈ $4.77 Million	+9.59%
2016-12-31	₩6.42 Billion ≈ $4.35 Million	-18.81%
2015-12-31	₩7.90 Billion ≈ $5.36 Million	--

About Green Cross Lab Cell Corporation

KQ:144510 Korea Diagnostics & Research

Market Cap

$140.94 Million

₩207.98 Billion KRW

Market Cap Rank

#17979 Global

#773 in Korea

Share Price

₩13840.00

Change (1 day)

-2.33%

52-Week Range

₩12710.00 - ₩27500.00

All Time High

₩126167.70